Vincere Biosciences, Inc.

Vincere Bio is a pharmaceutical company developing medicines to treat age-related diseases such as Parkinson's and kidney disease using a virtual cell platform that integrates human genetics and cellular network models to identify therapeutic targets. The company's lead program targeting USP30 for mitochondrial repair is expected to enter human trials within 12 months.